The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 6.9M (2021) → 15.8M (2025)
Together Pharma Ltd, through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. It offers cannabis oils and inflorescences. The company was incorporated in 1991 and is based in Ashkelon, Israel.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+0.9% YoY
YoY Growth Rate
Slow revenue growth
+109.6% YoY
YoY Growth Rate
EPS growth accelerating
0 ILS/ year
0.0% of revenue
Below sector average (18%)
Research and development spending
~13 months
12M ILS cash & investments
Quarterly Free Cash Flow
↓ Burn rate worsening
Adequate runway but may need to raise capital within 2 years
Together Pharma is growing revenue at 1% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Earnings growing 25%+ a year. The compounder zone.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
FCF margin between 0% and 10%. Some cash from sales, but not a lot.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
